Chapter 8: The Skin
- Introduction
- 8.1 Principles of Assessment
- 8.2 Disfigurement
- 8.3 Scars and Skin Grafts
- 8.4 Contact Dermatitis6–18
- 8.5 Natural Rubber Latex Allergy20–24
- 8.6 Skin Cancer1
- 8.7 Criteria for Rating Permanent Impairment due to Skin Disorders
- Example 8–1: Allergic Contact Dermatitis
- Example 8–2: Thermal Burn Scarring
- Example 8–3: Occupational Leukoderma
- Example 8–4: Thermal Burn with Hypertrophic Scarring
- Example 8–5: Chronic Hand Dermatitis
- Example 8–6: Allergic Contact Dermatitis
- Example 8–7: Allergic Contact Dermatitis
- Example 8–8: Latex Allergy and Eczema
- Example 8–9: Atopic Dermatitis
- Example 8–10: Atopic Dermatitis
- Example 8–11: Atopic Dermatitis
- Example 8–12: Nail Dystrophy and Anonychia
- Example 8–13: Neurodermatitis and Occupational Contact Dermatitis
- Example 8–14: Thermal Burn Scarring
- Example 8–15: Psoriasis with Pustular Flares
- Example 8–16: Skin Cancer
- Example 8–17: Follicular Occlusive Triad
- Example 8–18: Pemphigus Vulgaris
- Example 8–19: Thermal Burn Scarring and Dyspnea
- Example 8–20: Mycosis Fungoides
- Example 8–21: Xeroderma Pigmentosum
- Example 8–22: Epidermolysis Bullosa Dystrophica
- 8.8 Skin Impairment Evaluation Summary
- References
-
1.
Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S. Fitzpatrick's Dermatology in General Medicine. New York, NY: McGraw-Hill Professional; 2003.
-
2.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216.
-
3.
Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107(5):707–713.
-
4.
Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10–19.
-
5.
Jemec GB, Wulf HC. The applicability of clinical scoring systems: SCORAD and PASI in psoriasis and atopic dermatitis. Acta Derm Venereol. 1997;77(5):392–393.
-
6.
Rietschel RL, Fowler JF, Fisher AA. Fisher's Contact Dermatitis. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001.
-
7.
Adams RM. Occupational Skin Disease. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1999.
-
8.
Taylor JS, ed. Occupational dermatoses. Dermatol Clin North Am. 1994;12:461–600.
-
9.
Sherertz EF, Storrs FJ. Occupational contact dermatitis. In: Rosenstock L, Cullen M, eds. Textbook of Clinical Occupational and Environmental Medicine. Philadelphia, Pa: WB Saunders Co; 1994.
-
10.
Nethercott JR, Gallant C. Disability due to occupational contact dermatitis. Occup Med. 1986;1:199–204.
-
11.
Hogan DJ, Dannaker CJ, Maibach HI. The prognosis of contact dermatitis. J Am Acad Dermatol. 1990;23:300–307.
-
12.
Wigger-Alberti W, Elsner P. Preventive measures in contact dermatitis. Clin Dermatol. 1997;15:661–665.
-
13.
Drake L, Dorner W, Goltz RW, et al.Guidelines of care for contact dermatitis. J Am Acad Dermatol. 1995;32:109–113.
-
14.
Skoet R, Zachariae R, Agner T. Contact dermatitis and quality of life: a structured review of the literature. Br J Dermatol. 2003;149(3):452–456.
-
15.
Cvetkovski RS, Zachariae R, Jensen H, Olsen J, Johansen JD, Agner T. Prognosis of occupational hand eczema: a follow-up study. Arch Dermatol. 2006;142(3):305–311.
-
16.
Holness DL. Results of a quality of life questionnaire in a patch test clinic population. Contact Dermatitis. 2001;44(2):80–84.
-
17.
Belsito DV. Occupational contact dermatitis: etiology, prevalence, and resultant impairment/disability. J Am Acad Dermatol. 2005;53(2):303–313.
-
18.
Kadyk DL, McCarter K, Achen F, Belsito DV. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol. 2003;49(6):1037–1048.
-
19.
Sajjachareonpong P, Cahill J, Keegel T, Saunders H, Nixon R. Persistent post-occupational dermatitis. Contact Dermatitis. 2004;51(5–6):278–283.
-
20.
Preventing Allergic Reaction to Natural Rubber Latex in the Workplace. Cincinnati, Ohio: National Institute for Occupational Safety and Health; 1997. Publication 97–135.
-
21.
Tarlo SM, Sussman GL, Holness DL. Latex sensitivity in dental students and staff: a cross-sectional study. J Allergy Clin Immunol. 1997;99:396–401.
-
22.
Taylor JS, Wattanakrai P, Charous BL, Ownby DR. Year Book focus: latex allergy. In: Thiers BH, Lang PG, eds. 1999 Year Book of Dermatology and Dermatologic Surgery. St Louis, Mo: Mosby, St Louis University Press; 1999:1–44.
-
23.
Fink JN, ed. Latex allergy. Immunol Allergy Clin North Am. 1995;15:1–179.
-
24.
DeGroot H, DeJong N, Duijoter E, VanWyk RG, et al.Prevalence of natural rubber latex allergy (Type I and Type IV) in laboratory workers in the Netherlands. Contact Dermatitis. 1993;38:159–163.
-
25.
Fisher AA. Permanent loss of fingernails from sensitization and reaction to acrylics in a preparation designed to make artificial nails. J Dermatol Surg Oncol. 1980;6:70–71.
-
26.
Zuberbier T, Orlow SJ, Paller AS, et al.Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):226–232.
-
27.
Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol. 2006;154(4):719–725.
-
28.
Holm EA, Esmann S, Jemec GB. The handicap caused by atopic dermatitis–sick leave and job avoidance. J Eur Acad Dermatol Venereol. 2006;20(3):255–259.
-
29.
Fowler JF, Ghosh A, Sung J, et al.Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol. 2006;54(3):448–457.
-
30.
Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004;51(5):704–708.
-
31.
Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 pt 1):401–407.
-
32.
Pettey AA, Balkrishnan R, Rapp SR, Fleischer AB, Feldman SR. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol. 2003;49(2):271–275.
-
33.
Finlay AY, Khru GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol. 1990;123:751–756.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 44 | 44 | 6 |
